Neuro-oncology Caregiver Intervention Associated With Changes in C-Reactive Protein
- PMID: 40266659
- DOI: 10.1097/NCC.0000000000001507
Neuro-oncology Caregiver Intervention Associated With Changes in C-Reactive Protein
Abstract
Background: Stress biomarkers are documented in neuro-oncology family caregivers, although those reported to date are not routinely assessed in primary care, limiting their clinical utility.
Objective: This secondary analysis explored the impact of an 8-week, nurse-caregiver collaborative problem-solving intervention on a clinically relevant biomarker (C-reactive protein [CRP]) in adult neuro-oncology family caregivers.
Interventions/methods: As part of a randomized clinical trial to evaluate the effectiveness of a problem-solving intervention, CRP levels were obtained from 80 caregivers of persons with a primary malignant brain tumor at baseline and immediately following the intervention (intervention n = 57, control n = 23). Analysis used generalized linear modeling and evaluation of change in cardiac risk over time.
Results: Exploratory analysis found a significant (P < .03) time × group interaction; mean CRP in the intervention group decreased over time (mean = 1.11-0.88), whereas that in the control group increased over time (mean = 0.63-1.30). A higher number of caregivers in the control group (50%) had an increase in cardiovascular risk defined by CRP level compared with those in the intervention group (11%).
Conclusions: Results suggest CRP may be a clinically relevant measure of caregiver stress, which is readily used in primary care practice.
Implications for practice: Given the observed association between CRP levels and psychological stress among this cohort of neuro-oncology caregivers, primary care providers should consider incorporating CRP testing as part of routine assessments for caregiver health. This could facilitate early identification of heightened stress levels and associated cardiovascular risk, enabling timely interventions to support caregiver well-being.
Trial registration: ClinicalTrials.gov NCT02058745.
Keywords: Brain tumor; C-reactive protein; Caregiver; Family; Intervention; Neuro-oncology.
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
F.B. is a speaker for Medscape. The other authors have no funding or conflicts of interest to disclose.
References
-
- Loughan AR, Braun SE, Lanoye A. Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary utility in adult neuro-oncology. Neurooncol Pract. 2019;6(4):289–296.
-
- Loughan AR, Braun SE, Lanoye A. Executive dysfunction in neuro-oncology: behavior rating inventory of executive function in adult primary brain tumor patients. Appl Neuropsychol Adult. 2020;27(5):393–402.
-
- Braun SE, Lanoye A, Aslanzadeh FJ, Loughan AR. Subjective executive dysfunction in patients with primary brain tumors and their informants: relationships with neurocognitive, psychological, and daily functioning. Brain Inj. 2021;35(14):1665–1673.
-
- Loughan AR, Reid M, Willis KD, et al. The burden of a brain tumor: guiding patient centric care in neuro-oncology. J Neurooncol. 2022;157(3):487–498.
-
- Oh TK, Song IA, Kwon JE, Lee S, Choi HR, Jeon YT. Decreased income, unemployment, and disability after craniotomy for brain tumor removal: a South Korean nationwide cohort study. Support Care Cancer. 2022;30(2):1663–1671.
Associated data
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
